Press Release

Myoform Launches Blood Test Upload — Real-Time Biology Meets Precision Nutrition

Myoform blood test upload
London, UK / Mar 31, 2026 / Myoform

Myoform, the AI-driven precision nutrition platform, today announced the launch of its blood test upload capability, enabling users to integrate blood biomarker data directly into their personalised supplement formulation.

The launch allows users to upload results from any major blood testing provider, including Function Health, Superpower, and Thriva, as well as results from their own GP. Once uploaded, Myoform’s AI cross-references those biomarkers against the user’s genetic profile and 20,000+ peer-reviewed studies to dynamically recalibrate their personalised formulation.

Where genetics reveal the blueprint you were born with, blood reveals how your body is performing right now. Hormone levels shift. Nutrient deficiencies emerge. Cardiovascular markers change. Your supplement needs change with them.

Theo Wiley, founder and CEO of Myoform, said:

“Blood is one of the most powerful data sets available, but it’s one piece of a much larger picture. Whilst we started with genetics, the foundation, Myoform was always built to ingest the full picture of your biology. Every test you take, every physical, every marker feeds a single, continuously improving formulation. We’re not a blood testing or a genetics company. We’re a precision engine that gets smarter with every data point you give it.”

The launch follows Myoform’s public debut in January 2026. Blood test upload is available to all active subscribers effective immediately.

###
About Myoform

Myoform is an AI-driven precision nutrition platform built on whole genome sequencing, blood biomarkers, wearable data, and lifestyle inputs. Its mission is to end the era of generic supplementation and replace it with formulations built entirely around your biology.

Press Contact
Theo Wiley
theo@myoform.io
Myoform
Strategic intelligence for the future of health.

We break down how fitness, wellness, and healthcare are converging — and what it means for business, culture, and capital.

No thanks.